SCHEMBL21136729

SCHEMBL21136729

CNc1cnc2c(F)c(Br)c(F)cc2c1N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.41
ALK Q9UM73 2/20 0.39
KCNH2 Q12809 2/20 0.39
KIT P10721 2/20 0.38
BACE1 P56817 3/20 0.38
MAPK8 P45983 1/20 0.38
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37
MAP4K4 O95819 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136816 0.87 GPR119 (0.43) GPR119ALKKCNH2KITCKS1B
SCHEMBL21136770 0.83 KRAS (0.41) GPR119ALKKITBACE1CKS1B
SCHEMBL21137556 0.81 GPR119 (0.41) GPR119ALKKCNH2KITBACE1
SCHEMBL21136711 0.81 MAPK8 (0.41) GPR119ALKKCNH2KITBACE1
SCHEMBL16647196 0.79 KIT (0.52) GPR119KCNH2KITBACE1MAPT
SCHEMBL21137337 0.77 CXCR2 (0.41) GPR119ALKMAPK8MAPTCDK9
SCHEMBL16636900 0.77 MAPK8 (0.39) GPR119KCNH2KITMAPK8CKS1B
SCHEMBL16636974 0.76 MAPK8 (0.39) GPR119KCNH2KITMAPK8CKS1B
SCHEMBL25333920 0.75 GBA1 (0.44) GPR119KCNH2KITBACE1CKS1B
SCHEMBL20570346 0.75 NR1H2 (0.46) GPR119KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed